Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs
Has this study been replicated?
The atlas records 1 replication of this study. Recorded outcomes: 1 failed.
Replications
- Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs, Mantis et al. (2017). Outcome recorded: failed.
we found that coadministration with iRGD peptide did not have an impact on permeability of the chemotherapeutic agent doxorubicin (DOX)
View paper
Other studies in the atlas
Failed replications · Successful replications · All browse pages